Boliden’s revenues during the quarter totalled SEK 9 287 million (SEK 8 471 m) and the operating profit, excluding revaluation of process inventory, was SEK 711 million (SEK 603 m). Higher zinc prices and a weaker Swedish krona compensated for lower grades and maintenance shutdowns. “It was an eventful quarter. The new facilities at Garpenberg are performing well and market terms have improved. But at the same time, after two quarters of higher copper grades at Aitik, we are now mining ore sections with lower grades. We have also, as previously announced, suffered a tank breakdown at the Kokkola smelter which had impact on the production in the quarter. In October, we were granted permission to increase production at the Aitik mine to 45 million tonnes per year and we took over the Finnish copper mine Kylylahti, along with an extensive portfolio of exploration rights,” says Boliden’s President & CEO, Lennart Evrell. Boliden Smelters reported a return to full production at Odda after an extended period of limited production and this, together with the cost-cutting measures implemented at Rönnskär, had a positive effect on profits. Rising zinc prices resulted in higher realised treatment charges and increases in the values of “free metals”. Boliden Mines was affected by the fact that mining at Aitik occurred in areas with lower copper and gold grades. The Business Area was, however, positively affected by higher zinc prices, a weaker Swedish krona, and increased volumes from Garpenberg, where the ramping up of production is proceeding according to plan and is expected to total 2,1million tonnes for 2014 as a whole. “Analysing the metals market is difficult, and there are indications of a slight fall in demand and an increase in supply. Boliden will continue to implement measures that enhance efficiency and targeted action programmes that boost competitiveness. We have concluded a new collective agreement for the Tara mine and are now implementing the new organisation, while at Rönnskär, work continues with stabilisation of production processes and reductions in costs,” says Lennart Evrell. For further information, please contact: Marcela Sylvander, Group Communications, tel: +46 733 244 55 12 Sophie Arnius, Investor Relations, tel: +46 70 590 80 72 Boliden is a metals company with a commitment to sustainable development. Our roots are Nordic, but our business is global. The company’s core competence is within the fields of exploration, mining, smelting and metals recycling. Boliden has a total of approximately 4,800 employees and an annual turnover of approximately SEK 34 billion. Its share is listed on NASDAQ OMX Stockholm, segment Large Cap. www (http://www.boliden.com).boliden.com (http://www.boliden.com)
Boliden’s Q3: Improved terms and lower grades at Aitik
Top 10 Most Recent News Articles
Qonto's Banking License Raises the Stakes in Europe
A regulatory stamp can look dull on paper, yet this one changes the machinery underneath Qonto. The Paris-based finance platform has received a Credit Institution license from France's ACPR and the European Central Bank, giving it a route to offer broader lending and savings products directly to small and midsize businesses across Europe. That is a serious corporate...
Continue Reading
LifeVac's 7,000 Reported Saves Deserve Careful Context
Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...
Continue Reading
Aurora Innovation Faces Legal Probe After Stock Plunge
Aurora's Troubles Draw Legal Scrutiny Looks like Aurora Innovation’s in the hot seat again, and not in a good way. When you see Kessler Topaz Meltzer & Check, LLP throwing their name into the mix, you know it’s getting serious. This legal eagle firm is poking around, seeing if Aurora stepped over the line with investors after their latest stumble—a production delay...
Continue Reading
Navan’s Travel Survey Sells Friction as a Business Case
A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...
Continue Reading
Bank of America AML Claims Put Controls Under Fire
A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...
Continue Reading
Animal Parasite Market Growth Has a Resistance Catch
Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...
Continue Reading
Madrigal Pharmaceuticals Faces Legal Scrutiny Over Data
Legal Storm Brews for Madrigal Pharmaceuticals Watch out, here comes another storm for Madrigal Pharmaceuticals, folks. This ain't no small drizzle either; it's a full-on legal monsoon, and it's soaked straight through the walls of their executive suite. We're talking a whistleblower sending alarm bells ringing about data fudging and some dodgy boardroom maneuvers—as if...
Continue Reading
Red Cat Stock Drama: Revenue Targets and Legal Waves
Red Cat's Revenue Predictions Crash and Burn Sitting there on August 6, 2026, Red Cat Holdings had everyone believing they were on a fast track to hitting a hefty revenue target: $150–$180 million for FY2026. CEO Jeffrey Thompson didn't mince words, boasting confidence like a captain before a storm. Fast forward three months, and they're waving the white flag, tossing...
Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny
Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...
Continue Reading
BNY's December Conference Slot Merits a Careful Listen
A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...
Continue ReadingTop 5 Most Recently Viewed Articles
Wicked Cutz, Cinnabon Team Up for Bacon Jerky Debut
Ever thought you'd see the day when your protein snack could taste like a cinnamon roll? Well, folks, that day has arrived. Wicked Cutz, a force in the meat snack industry, and Cinnabon, the undisputed champs of cinnamon rolls, have rolled out a product that's bound to raise some eyebrows: bacon jerky with a sweet pastry twist. Why Bacon Jerky? You might be wondering, why...
Continue Reading
10 High-Yielding Small-Cap Stocks Under $15 in 2024
In the ever-evolving landscape of the stock market, small-cap stocks can be a gold mine for investors seeking high yields without breaking the bank. As we navigate through 2024, let's delve into a curated list of 10 small-cap stocks trading under $15 that offer attractive dividend yields. But remember, high yields can be as enticing as they are perilous, so tread with...
Continue Reading
Frazier Life Sciences Secures Over $630M for Growth Initiatives
Frazier Life Sciences (FLS) raised over $630 million back in 2024, which got everyone buzzing on the trading floor. This wasn't just pocket change; it came from an oversubscribed fundraise that saw new and existing investors jumping on board like it was Black Friday. Talk about a cash infusion! The Public Fund has amassed around $1.7 billion since its launch three years...
Continue Reading
1847 Holdings LLC Achieves Milestone with $11.1M Offering
1847 Holdings LLC Successfully Completes Public Offering 1847 Holdings LLC (NYSE American: EFSH), a company dedicated to investing in high-potential middle-market businesses, recently announced an exciting achievement. The firm has successfully closed its public offering, resulting in gross proceeds of $11.1 million. This accomplishment reflects the company's continued...
Continue Reading
Live Nation Entertainment's Stock Analysis Amid Sell-Off
Understanding Live Nation Entertainment's Recent Stock Movements The trading landscape for Live Nation Entertainment, Inc. (LYV) has seen quieter activity following a significant sell-off of 6.5%. Investors and market analysts are closely observing whether this stock will continue its downward trajectory. Technical Analysis: Support and Resistance Levels Identifying Key...
Continue Reading